Phibro Animal Health Corporation (NASDAQ:PAHC) declared a quarterly dividend on Tuesday, July 25th, Wall Street Journal reports. Shareholders of record on Wednesday, September 6th will be paid a dividend of 0.10 per share on Wednesday, September 27th. This represents a $0.40 annualized dividend and a yield of 1.01%. The ex-dividend date of this dividend is Friday, September 1st.
Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) traded up 0.89% during mid-day trading on Friday, hitting $39.65. The stock had a trading volume of 163,576 shares. Phibro Animal Health Corporation has a 12 month low of $20.14 and a 12 month high of $39.95. The stock’s 50-day moving average is $38.03 and its 200 day moving average is $32.23. The company has a market cap of $1.57 billion, a PE ratio of 24.63 and a beta of 1.35.
In other Phibro Animal Health Corporation news, insider Jack Bendheim sold 48,000 shares of Phibro Animal Health Corporation stock in a transaction dated Thursday, May 25th. The stock was sold at an average price of $34.67, for a total transaction of $1,664,160.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder Bfi Co., Llc sold 16,000 shares of Phibro Animal Health Corporation stock in a transaction dated Thursday, July 6th. The stock was sold at an average price of $36.00, for a total value of $576,000.00. Following the sale, the insider now directly owns 28,000 shares of the company’s stock, valued at approximately $1,008,000. The disclosure for this sale can be found here. Insiders sold a total of 352,000 shares of company stock valued at $12,599,200 in the last three months. Insiders own 48.09% of the company’s stock.
PAHC has been the topic of several recent research reports. Zacks Investment Research raised Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 target price on the stock in a research report on Thursday, May 11th. BidaskClub raised Phibro Animal Health Corporation from a “buy” rating to a “strong-buy” rating in a research report on Thursday, June 22nd. Piper Jaffray Companies set a $35.00 price objective on Phibro Animal Health Corporation and gave the stock a “buy” rating in a research report on Friday, July 21st. Finally, Credit Suisse Group cut Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and raised their price objective for the stock from $29.00 to $36.00 in a research report on Friday, June 2nd. Two analysts have rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $30.50.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.